TRIM56 and gastric cancer: Although the inhibition of NNMT proteasomal degradation has been reported in gastric cancer,[28] we here further characterized TRIM56 as the key E3 ubiquitin ligase for NNMT ubiquitination, and identified lysine 23 and 210 as its major ubiquitination sites.